Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3826
ThredUp
TDUP
$746M
| $153K | ﹤0.01% |
60,519
+44,755
| +284% | +$83.4K |
|
3827
Matrix Service
MTRX
$326M
| $152K | ﹤0.01% |
28,220
+13,259
| +89% | +$92K |
|
|
GPMT
3828
Granite Point Mortgage Trust
GPMT
$69M
| $152K | ﹤0.01% |
30,674
+5,470
| +22% | +$31.8K |
|
3829
Evolus
EOLS
$385M
| $152K | ﹤0.01% |
17,970
+8,461
| +89% | +$76.5K |
|
3830
Hippo Holdings
HIPO
$830M
| $152K | ﹤0.01% |
9,359
+2,670
| +40% | +$43.6K |
|
3831
State Street SPDR S&P China ETF
GXC
$462M
| $152K | ﹤0.01% |
1,844
+1,455
| +374% | +$122K |
|
3832
Funko
FNKO
$326M
| $152K | ﹤0.01% |
16,090
+7,541
| +88% | +$78.2K |
|
|
QUOT
3833
DELISTED
Quotient Technology Inc
QUOT
| $150K | ﹤0.01% |
45,786
-17,843
| -28% | -$63.3K |
|
|
BTX
3834
BlackRock Technology and Private Equity Term Trust
BTX
$940M
| $150K | ﹤0.01% |
16,235
+448
| +3% | +$3.33K |
|
3835
West Bancorporation
WTBA
$478M
| $149K | ﹤0.01% |
8,182
+3,831
| +88% | +$81.4K |
|
3836
Heron Therapeutics
HRTX
$93.9M
| $149K | ﹤0.01% |
98,933
+24,314
| +33% | +$60.9K |
|
3837
Heritage Insurance Holdings
HRTG
$889M
| $149K | ﹤0.01% |
48,421
| – | – |
|
|
CWAN
3838
DELISTED
Clearwater Analytics
CWAN
| $149K | ﹤0.01% |
9,343
| – | – |
|
3839
Viemed Healthcare
VMD
$447M
| $149K | ﹤0.01% |
15,396
+495
| +3% | +$4.32K |
|
3840
C4 Therapeutics
CCCC
$385M
| $149K | ﹤0.01% |
47,363
-56,285
| -54% | -$331K |
|
|
LUNA
3841
DELISTED
Luna Innovations Incorporated
LUNA
| $148K | ﹤0.01% |
+20,653
| New | +$182K |
|
3842
Innodata
INOD
$2.05B
| $148K | ﹤0.01% |
+17,387
| New | +$98.3K |
|
3843
PLAYSTUDIOS Inc
MYPS
$77.9M
| $148K | ﹤0.01% |
40,194
+18,916
| +89% | +$76.6K |
|
3844
Entrada Therapeutics
TRDA
$264M
| $148K | ﹤0.01% |
10,228
-544
| -5% | -$7.26K |
|
|
GOCO
3845
DELISTED
GoHealth
GOCO
| $148K | ﹤0.01% |
9,101
+5,455
| +150% | +$84.2K |
|
3846
Invesco Semiconductors ETF
PSI
$2.29B
| $148K | ﹤0.01% |
3,591
| – | – |
|
|
UFOX
3847
Defiance Space and Connective Tech ETF
UFOX
$835M
| $148K | ﹤0.01% |
+4,500
| New | +$144K |
|
|
LOGC
3848
DELISTED
ContextLogic
LOGC
| $147K | ﹤0.01% |
10,995
+4,610
| +72% | +$78.4K |
|
3849
CALL
Fidelity National Financial
FNF
$13.9B
| $147K | ﹤0.01% |
+4,200
| New | +$165K |
|
|
HLVX
3850
DELISTED
HilleVax
HLVX
| $147K | ﹤0.01% |
8,868
+4,180
| +89% | +$66.9K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.